Related Experiment Video
Updated: Apr 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predictors of Outcome in Ulcerative Colitis
Matti Waterman1, Jo Knight, Amreen Dinani
1*Zane Cohen Centre for Digestive Diseases, Division of Gastroenterology, Mount Sinai Hospital, Toronto, ON, Canada; †Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel; ‡Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Neuroscience Research, Toronto, ON, Canada; §University of Toronto, Toronto, ON, Canada; ||Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; and ¶Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
Older age and proximal disease location predict a more severe course of ulcerative colitis (UC). Genetic and serum markers did not predict UC severity, indicating a need for new biomarkers.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Ulcerative colitis (UC) affects many patients with intermittent disease, and colectomy is common.
- Predictors of a poor disease course in UC are not well-defined.
- Identifying prognostic markers is crucial for managing UC.
Purpose of the Study:
- To identify clinical and genetic markers that predict the prognosis of ulcerative colitis.
- To investigate associations between disease location, age at diagnosis, and UC severity.
- To evaluate the utility of genetic and serum markers in predicting UC outcomes.
Main Methods:
- Retrospective analysis of 601 ulcerative colitis patients with ≥5 years of follow-up.
- Genotyping using Immunochip for immune-mediated inflammatory disorder loci.
- Assessment of serum markers (pANCA, ASCA, CBir1, OmpC) and clinical data.
Main Results:
- Severe UC was associated with proximal disease location (30% vs. 13-21%) and older age at diagnosis (>40 years).
- Proximal disease extension correlated with disease severity and earlier prednisone initiation.
- No tested genetic or serum markers predicted severe UC, disease extension, or colectomy.
Conclusions:
- Older age and proximal disease location at diagnosis are clinical predictors of severe ulcerative colitis.
- Current genetic and serum markers are not effective in predicting UC prognosis.
- Further research is needed to discover reliable biomarkers for UC outcomes.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

